Glucocorticoid enhancement of food exposure therapy in Binge Eating Disorder
- Conditions
- Binge Eating DisorderMedDRA version: 24.0Level: PTClassification code: 10004716Term: Binge eating Class: 100000004873Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
- Registration Number
- CTIS2024-515475-35-00
- Lead Sponsor
- niversitaetsmedizin Goettingen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 50
Patients with BED according to DSM-5, Male or female patients aged between 18 and 40 (the upper age limit was chosen to minimise potential confounding effects by hormonal changes related to menopause), Written informed consent obtained according to international guidelines and local laws, Ability to understand the nature of the trial and the trial related procedures and to comply with them.
systemic (i.v. or oral) glucocorticoid treatment within the last 3 months, known pheochromocytoma, Simultaneous participation in another interventional trial, Pregnant or breastfeeding females, current diagnosis of a psychotic, bipolar, or substance use disorder, severe somatic illness (e.g. cancer, cardiovascular disease, instable diabetes mellitus; blood pressure = 160/100 mmHg at rest and/or current treatment of hypertensive crisis within last 6 months), current or planned use of psychotropic medication (during the period of the study), current or planned psychotherapy (during the period of the study), known hypersensitivity to hydrocortisone, known hereditary galactose intolerance, known lactase deficiency, known glucose-galactose malabsorption
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method